1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS
    3.
    发明申请
    1, 3, 4-BENZOTRIAZEPIN-2-ONE SALTS AND THEIR USE AS CCK RECEPTOR LIGANDS 审中-公开
    1,3,4-苯并噻唑-2-酮盐及其作为CCK受体配体使用

    公开(公告)号:WO2004101533A1

    公开(公告)日:2004-11-25

    申请号:PCT/US2004/012914

    申请日:2004-04-27

    IPC分类号: C07D255/04

    摘要: This invention relates to pharmaceutically acceptable salts of compounds of formula (I) wherein: W is N or N + -O - ; R 2 is an optionally substituted C 1 to C 18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms. R 3 is -(CR 11 R 12 ) m -X-(CR 13 R 14 ) p -R 9 ; m is 0, 1, 2, 3 or 4; p is 0, 1 or 2; X is a bond, -CR 15 =CR 16 -, -C≡C-, C(O)NH, NHC(O), C(O)NMe, NMeC(O), C(O)O, NHC(O)NH, NHC(O)O, OC(O)NH, NH, O, CO, SO 2 , SO 2 NH, C(O)NHNH, R 9 is H ; C 1 to C 6 alkyl ; or phenyl, naphthyl, pyridyl, benzimidazolyl, indazolyl, quinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, indolinyl, isoindolinyl, indolyl, isoindolyl or 2-pyridonyl substituted with -L-Q. R 4 is an optionally substituted C 1 to C 18 hydrocarbyl group wherein up to three C atoms may optionally be replaced by N, O and/or S atoms ; and Such salts are useful, for example, for the treatment of gastrin related disorders.

    摘要翻译: 本发明涉及式(I)化合物的药学上可接受的盐,其中:W是N或N + O - ; R 2是任选取代的C 1 -C 18烃基,其中最多三个C原子可以任选地被N,O和/或S原子替代。 R 3是 - (CR 11 R 12)m -X-(CR 13 R 14)p -R 9; m为0,1,2,3或4; p为0,1或2; X是一个键,-CR 15 = CR 16 - ,-C = C - ,C(O)NH,NHC(O),C(O)NMe,NMeC(O),C(O)O ,NHC(O)NH,NHC(O)O,OC(O)NH,NH,O,CO,SO 2,SO 2 NH,C(O)NHNH,R 9是H; C1至C6烷基; 或苯基,萘基,吡啶基,苯并咪唑基,吲唑基,喹啉基,异喹啉基,四氢异喹啉基,二氢吲哚基,异吲哚啉基,吲哚基,异吲哚基或被-L-Q取代的2-吡啶酮基。 R 4是任选取代的C 1至C 18烃基,其中最多三个C原子可以任选地被N,O和/或S原子替代; 并且这样的盐可用于例如用于治疗胃泌素相关病症。